Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.520
0.00 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
2.495
-0.025 (-0.98%)
After-hours: Apr 24, 2026, 7:13 PM EDT

CNTB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
0.0626.03---
Revenue Growth (YoY)
-99.75%----
Gross Profit
0.0626.03---
Selling, General & Admin
20.3417.4316.0520.8119.01
Research & Development
37.827.865396.6380.5
Other Operating Expenses
----1.08-1.85
Operating Expenses
58.1445.2969.06116.3697.66
Operating Income
-58.07-19.25-69.06-116.36-97.66
Interest Expense
----0.02-0.01
Interest & Investment Income
2.274.455.221.810.17
Currency Exchange Gain (Loss)
---1.47-0.52
Other Non Operating Income (Expenses)
0.522.591.85--103.98
EBT Excluding Unusual Items
-55.28-12.21-61.99-113.1-202
Asset Writedown
----4.7-
Other Unusual Items
--3.2---
Pretax Income
-55.28-15.41-61.99-117.79-202
Income Tax Expense
0.20.220.120.30.27
Earnings From Continuing Operations
-55.48-15.63-62.11-118.09-202.27
Net Income
-55.48-15.63-62.11-118.09-202.27
Net Income to Common
-55.48-15.63-62.11-118.09-202.27
Shares Outstanding (Basic)
5655555552
Shares Outstanding (Diluted)
5655555552
Shares Change (YoY)
0.81%0.27%0.04%5.50%205.31%
EPS (Basic)
-1.00-0.28-1.13-2.15-3.88
EPS (Diluted)
-1.00-0.28-1.13-2.15-3.88
Free Cash Flow
-51.64-24.36-47.82-105.93-88.16
Free Cash Flow Per Share
-0.93-0.44-0.87-1.92-1.69
Gross Margin
100.00%100.00%---
Operating Margin
-90740.63%-73.95%---
Profit Margin
-86687.50%-60.03%---
Free Cash Flow Margin
-80687.50%-93.58%---
EBITDA
-57.37-18.59-68.34-115.63-97.17
EBITDA Margin
--71.42%---
D&A For EBITDA
0.70.660.720.730.49
EBIT
-58.07-19.25-69.06-116.36-97.66
EBIT Margin
--73.95%---
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q